24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publication dates

Leukemia Industry, December 2014 Market Reports from Top Publishers

You might be interested in: Flow Cytometry, Hematology, Therapeutics, more »


 
1-10 of about 200 reports for Leukemia

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

The Leukemia & Lymphoma Society, Inc. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Key elements such as swot analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs. The leukemia & lymphoma society, inc. - Strategic swot ...

EpiZyme, Inc. (EPZM) - Financial and Strategic SWOT Analysis Review

EpiZyme, Inc. (EPZM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

... Modifying enzymes, and others. The company partners with celgene, glaxosmithkline, eisai, the leukemia & lymphoma society and multiple myeloma research foundation. Epizyme is headquartered in cambridge, massachusetts ...

Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2014

Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

... leukemia- the report reviews key pipeline products under drug profile section which includes, product description, moa and r&d brief, licensing and collaboration details & other developmental activities ...

Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2014

Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

... Pipeline projects- coverage of the relapsed acute myeloid leukemia pipeline on the basis of target, moa, route of administration and molecule type- latest news and deals relating related to pipeline ...

Curis, Inc. (CRIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Curis, Inc. (CRIS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... Healthcare, deals summary, 2008 to ytd 2014 9curis, inc., Pharmaceuticals & healthcare, deal details 10partnerships 10curis enters into co-development agreement with the leukemia & lymphoma ...

Kancera AB (KAN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kancera AB (KAN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... And industrial research & development. Kancera has three drug projects, namely, ror inhibitors project (leukemia and solid tumors), project pfkfb3 (solid tumors) and epigenetic pharmaceutical development targeting ...

Acetylon Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Acetylon Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... And washington in the us and across europe. The company partners with celgene corporation, and the leukemia & lymphoma society. Acetylon is headquartered in boston, massachusetts, the us ...

Actinium Pharmaceuticals, Inc. (ATNM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Actinium Pharmaceuticals, Inc. (ATNM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2014
  • by Global Data

... leukemia and pre-clinical development. Atnm's products are used for the treatment of metastatic colorectal and prostate cancers, prevention of blood supply to and growth of solid cancers, and treatment ...

Leukemia Drug Pathway Analyzer 2014

Leukemia Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • November 2014
  • by Bioseeker

... Before. Its capabilities moves you beyond powerful competitive intelligence to an opportunity seeking tool which lets you, by means of both present and emerging scientific knowledge, analyze the leukemia ...

 Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-API Insights, 2014

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)-API Insights, 2014

  • $ 1 250
  • Industry report
  • November 2014
  • by Delve Insight

... Of the apis and intermediates being sourced from markets such as india and china.Delveinsight's, acute lymphocytic leukemia (all, acute lymphoblastic leukemia) -api insights, 2014 report describes ...

About 1 300 reports for Leukemia

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • April 2014
    28 pages
  • Cancer  

  • United States  

    North America  

View report >

16 Companies for Leukemia

Read our Company Profiles

Celgene Corp.

United States

GlaxoSmithKline P.L.C.

United States

Bristol-Myers Squibb Co.

United States

GlaxoSmithKline PLC

United Kingdom

Novartis Inc.

Switzerland

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.